#BEGIN_DRUGCARD DB03978

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C9H11NO2

# Chemical_IUPAC_Name:
(2S)-2-amino-3-(4-hydroxyphenyl)propanal

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Tyrosinal

# HET_ID:
TYB

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C9H11NO2/c10-8(6-11)5-7-1-3-9(12)4-2-7/h1-4,6,8,12H,5,10H2/t8-/m0/s1

# InChI_Key:
InChIKey=DXGAIOIQACHYRK-QMMMGPOBSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3978

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
165.1891

# Molecular_Weight_Mono:
165.078978601

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1Q11

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.08

# Predicted_LogS:
-1.8

# Predicted_Water_Solubility:
2.77e+00 g/l

# Primary_Accession_No:
DB03978

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
445993

# PubChem_Substance_ID:
46505540

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03134

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@](N)(CC1=CC=C(O)C=C1)C=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:49 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE017221

# Drug_Target_1_GenBank_ID_Protein:
46196960

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
tyrS

# Drug_Target_1_Gene_Sequence:
>1299 bp
ATGGCGGGCACCGGCCACACCCCGGAAGAGGCCCTGGCCCTCCTCAAGCGGGGGGCCGAG
GAGATCGTCCCCGAGGAAGAGCTTCTCGCCAAGCTCAAGGAGGGGCGGCCCCTCACGGTC
AAGCTCGGGGCCGACCCCACGAGGCCCGACCTGCACCTGGGCCACGCGGTGGTCCTGAGG
AAGATGCGCCAGTTCCAAGAGCTCGGCCACAAGGTGGTCCTCATCATCGGCGACTTCACC
GGGATGATCGGGGACCCTTCGGGCCGTTCCAAGACCCGGCCCCCCCTCACCCTCGAGGAG
ACCCGGGAGAACGCCAAGACCTACGTGGCCCAGGCGGGGAAGATCCTCAGGCAGGAGCCC
CACCTCTTTGAGCTCCGCTACAACTCCGAGTGGCTGGAGGGCCTCACCTTCAAGGAGGTG
GTGCGCCTCACCTCCCTCATGACCGTGGCCCAGATGCTGGAAAGGGAGGACTTTAAAAAG
CGGTACGAGGCGGGGATTCCCATCTCCCTGCACGAGCTTTTGTACCCCTTCGCCCAGGCC
TACGACTCCGTGGCCATAAGGGCCGACGTGGAAATGGGGGGCACGGACCAGCGCTTCAAC
CTCCTGGTGGGCCGGGAGGTGCAACGGGCCTACGGGCAAAGCCCCCAGGTCTGCTTCCTC
ATGCCCCTTCTCGTGGGCCTTGACGGGCGGGAGAAGATGAGCAAGAGCCTGGACAACTAC
ATCGGCCTCACCGAGCCCCCGGAGGCGATGTTCAAGAAGCTCATGCGGGTGCCGGACCCT
CTCCTCCCGAGCTACTTCCGCCTCCTCACGGACCTGGAGGAGGAGGAAATAGAGGCCCTC
CTAAAGGCGGGCCCCGTCCCCGCCCACCGGGTCCTCGCCCGCCTCCTCACCGCGGCCTAC
GCCCTGCCCCAGATCCCCCCCCGGATAGACCGGGCCTTTTACGAAAGCCTCGGCTACGCC
TGGGAGGCCTTCGGGCGGGACAAGGAGGCGGGCCCCGAGGAGGTAAGGAGGGCGGAAGCC
CGCTACGACGAGGTGGCCAAAGGGGGAATCCCCGAGGAGATCCCCGAGGTCACCATCCCC
GCCTCGGAGCTGAAGGAAGGCCGGATCTGGGTGGCGAGGCTTTTTACCTTAGCGGGCCTC
ACCCCCTCCAACGCCGAGGCGAGGAGGCTCATCCAGAACCGGGGCCTGAGGCTGGACGGG
GAGGTCCTCACCGACCCCATGCTCCAGGTGGACCTCTCCCGGCCCCGCATCCTGCAGCGG
GGCAAGGACCGCTTCGTGCGGGTGCGGCTTTCGGACTGA

# Drug_Target_1_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_1_General_References:
12110594	Yaremchuk A, Kriklivyi I, Tukalo M, Cusack S: Class I tyrosyl-tRNA synthetase has a class II mode of cognate tRNA recognition. EMBO J. 2002 Jul 15;21(14):3829-40.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3574

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
48719

# Drug_Target_1_Name:
Tyrosyl-tRNA synthetase

# Drug_Target_1_Number_of_Residues:
432

# Drug_Target_1_PDB_ID:
1H3E

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00579	tRNA-synt_1b

# Drug_Target_1_Protein_Sequence:
>Tyrosyl-tRNA synthetase
MAGTGHTPEEALALLKRGAEEIVPEEELLAKLKEGRPLTVKLGADPTRPDLHLGHAVVLR
KMRQFQELGHKVVLIIGDFTGMIGDPSGRSKTRPPLTLEETRENAKTYVAQAGKILRQEP
HLFELRYNSEWLEGLTFKEVVRLTSLMTVAQMLEREDFKKRYEAGIPISLHELLYPFAQA
YDSVAIRADVEMGGTDQRFNLLVGREVQRAYGQSPQVCFLMPLLVGLDGREKMSKSLDNY
IGLTEPPEAMFKKLMRVPDPLLPSYFRLLTDLEEEEIEALLKAGPVPAHRVLARLLTAAY
ALPQIPPRIDRAFYESLGYAWEAFGRDKEAGPEEVRRAEARYDEVAKGGIPEEIPEVTIP
ASELKEGRIWVARLFTLAGLTPSNAEARRLIQNRGLRLDGEVLTDPMLQVDLSRPRILQR
GKDRFVRVRLSD

# Drug_Target_1_Reaction:
ATP + L-tyrosine + tRNATyr = AMP + diphosphate + L-tyrosyl-tRNATyr

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the attachment of tyrosine to tRNA(Tyr) in a two-step reaction:tyrosine is first activated by ATP to form Tyr- AMP and then transferred to the acceptor end of tRNA(Tyr)

# Drug_Target_1_SwissProt_ID:
P83453

# Drug_Target_1_SwissProt_Name:
SYY_THET2

# Drug_Target_1_Synonyms:
EC 6.1.1.1
TyrRS
Tyrosine--tRNA ligase

# Drug_Target_1_Theoretical_pI:
6.44

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Periplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
D37970

# Drug_Target_2_GenBank_ID_Protein:
688417

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
pcp

# Drug_Target_2_Gene_Sequence:
>1764 bp
ATGAAGTCGTCAGCCGCAAAACAAACGGTCCTGTGTCTAAACCGTTACGCGGTCGTTGCT
TTGCCTCTCGCTATTGCTTCGTTCGCTGCGTTCGGCGCATCGCCCGCGTCCACACTGTGG
GCGCCCACCGACACGAAGGCGTTTGTAACGCCCGCCCAGGTCGAGGCGCGCAGTGCGGCG
CCGTTGCTCGAACTCGCCGCCGGCGAGACCGCGCATATCGTCGTCAGCCTCAAGCTTCGC
GACGAGGCGCAACTGAAGCAACTCGCGCAGGCAGTCAACCAGCCGGGCAACGCGCAGTTC
GGCAAATTCCTCAAGCGTCGGCAATTCCTCTCGCAATTCGCGCCGACCGAGGCGCAAGTG
CAGGCCGTCGTCGCGCATTTACGGAAGAACGGCTTCGTCAACATTCACGTCGTGCCGAAC
CGCCTGCTGATTTCCGCCGACGGCAGCGCCGGCGCCGTCAAAGCGGCCTTCAACACGCCG
CTGGTTCGCTATCAGCTGAACGGCAAGGCCGGCTACGCGAACACGGCGCCGGCACAGGTG
CCGCAGGATCTCGGCGAGATCGTCGGTTCGGTGCTCGGCTTGCAGAACGTCACGCGTGCC
CATCCGATGCTGAAGGTCGGCGAGCGTTCCGCCGCGAAGACGCTGGCCGCCGGTACGGCC
AAGGGCCACAATCCGACCGAGTTCCCAACGATCTACGACGCCAGCAGCGCGCCCACCGCG
GCGAACACGACGGTCGGCATCATCACGATCGGCGGCGTCTCGCAGACGCTTCAGGATCTC
CAGCAGTTCACCAGCGCGAATGGCCTTGCGTCCGTCAACACGCAGACGATCCAGACCGGA
TCGTCGAATGGCGACTACAGCGACGATCAGCAAGGCCAGGGTGAGTGGGACCTCGACAGC
CAGTCGATTGTCGGTTCCGCGGGCGGCGCGGTGCAGCAACTGCTGTTCTACATGGCCGAT
CAAAGCGCGTCCGGCAACACCGGCCTCACGCAGGCGTTCAATCAGGCGGTGTCCGATAAC
GTCGCGAAGGTGATCAACGTGTCGCTCGGCTGGTGTGAAGCCGATGCCAACGCTGACGGC
ACGCTGCAGGCCGAAGATCGCATCTTCGCGACGGCCGCGGCACAAGGGCAAACCTTCTCG
GTGTCGTCCGGCGATGAGGGCGTGTACGAATGCAACAACCGCGGCTACCCTGACGGCAGC
ACCTATTCGGTATCGTGGCCGGCCTCGTCGCCCAACGTGATCGCCGTCGGCGGCACGACG
CTTTACACGACGTCAGCAGGCGCCTACTCGAACGAAACCGTCTGGAACGAAGGGCTCGAC
AGCAACGGCAAGCTCTGGGCAACCGGCGGTGGCTACAGCGTGTACGAGTCGAAGCCGTCG
TGGCAGTCGGTGGTGAGCGGCACGCCGGGCCGGCGTCTGCTACCCGACATCTCCTTCGAC
GCGGCGCAGGGCACGGGCGCACTGATTTACAACTACGGCCAGCTTCAGCAGATCGGCGGG
ACGAGCCTCGCTTCGCCAATCTTCGTCGGGCTGTGGGCACGTTTGCAGAGCGCGAATTCG
AATAGCCTGGGCTTCCCCGCAGCCAGCTTTTACAGCGCCATTAGCTCGACGCCTTCGCTG
GTGCACGACGTGAAATCGGGTAACAACGGCTACGGCGGCTATGGTTACAACGCAGGCACC
GGTTGGGACTATCCGACCGGATGGGGAAGCCTCGATATTGCGAAGCTGTCCGCTTATATC
AGGAGCAACGGCTTTGGACATTGA

# Drug_Target_2_General_Function:
Not Available

# Drug_Target_2_General_References:
10488127	Oyama H, Abe S, Ushiyama S, Takahashi S, Oda K: Identification of catalytic residues of pepstatin-insensitive carboxyl proteinases from prokaryotes by site-directed mutagenesis. J Biol Chem. 1999 Sep 24;274(39):27815-22.
11323721	Wlodawer A, Li M, Dauter Z, Gustchina A, Uchida K, Oyama H, Dunn BM, Oda K: Carboxyl proteinase from Pseudomonas defines a novel family of subtilisin-like enzymes. Nat Struct Biol. 2001 May;8(5):442-6.
11747435	Wlodawer A, Li M, Gustchina A, Dauter Z, Uchida K, Oyama H, Goldfarb NE, Dunn BM, Oda K: Inhibitor complexes of the Pseudomonas serine-carboxyl proteinase. Biochemistry. 2001 Dec 25;40(51):15602-11.
7929375	Oda K, Takahashi T, Tokuda Y, Shibano Y, Takahashi S: Cloning, nucleotide sequence, and expression of an isovaleryl pepstatin-insensitive carboxyl proteinase gene from Pseudomonas sp. 101. J Biol Chem. 1994 Oct 21;269(42):26518-24.
8576087	Hayashi K, Izu H, Oda K, Fukuhara K, Matsuo M, Takano R, Hara S: The primary structure of pepstatin-insensitive carboxyl proteinase produced by Pseudomonas sp. No. 101. J Biochem (Tokyo). 1995 Oct;118(4):738-44.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3526

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
61073

# Drug_Target_2_Name:
Pseudomonalisin

# Drug_Target_2_Number_of_Residues:
587

# Drug_Target_2_PDB_ID:
1GA6

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00082	Peptidase_S8
PF09286	Pro-kuma_activ

# Drug_Target_2_Protein_Sequence:
>Pseudomonalisin precursor
MKSSAAKQTVLCLNRYAVVALPLAIASFAAFGASPASTLWAPTDTKAFVTPAQVEARSAA
PLLELAAGETAHIVVSLKLRDEAQLKQLAQAVNQPGNAQFGKFLKRRQFLSQFAPTEAQV
QAVVAHLRKNGFVNIHVVPNRLLISADGSAGAVKAAFNTPLVRYQLNGKAGYANTAPAQV
PQDLGEIVGSVLGLQNVTRAHPMLKVGERSAAKTLAAGTAKGHNPTEFPTIYDASSAPTA
ANTTVGIITIGGVSQTLQDLQQFTSANGLASVNTQTIQTGSSNGDYSDDQQGQGEWDLDS
QSIVGSAGGAVQQLLFYMADQSASGNTGLTQAFNQAVSDNVAKVINVSLGWCEADANADG
TLQAEDRIFATAAAQGQTFSVSSGDEGVYECNNRGYPDGSTYSVSWPASSPNVIAVGGTT
LYTTSAGAYSNETVWNEGLDSNGKLWATGGGYSVYESKPSWQSVVSGTPGRRLLPDISFD
AAQGTGALIYNYGQLQQIGGTSLASPIFVGLWARLQSANSNSLGFPAASFYSAISSTPSL
VHDVKSGNNGYGGYGYNAGTGWDYPTGWGSLDIAKLSAYIRSNGFGH

# Drug_Target_2_Reaction:
Hydrolysis of the B chain of insulin at -Glu13!Ala-, -Leu15!Tyr- and -Phe25!Tyr-, and angiotensin I at -Tyr4!Ile-. A good synthetic substrate is Lys-Pro-Ile-Glu-Phe!Phe(NO2)-Arg-Leu.

# Drug_Target_2_Signals:
Not Available

# Drug_Target_2_Specific_Function:
Hydrolysis of the B chain of insulin at 13- Glu-|-Ala-14, 15-Leu-|-Tyr-16 and 25-Phe-|-Tyr-26 and angiotensin I at 4-Tyr-|-Ile-5. A good synthetic substrate is Lys-Pro-Ile-Glu- Phe-|-Phe(NO(2))-Arg-Leu

# Drug_Target_2_SwissProt_ID:
P42790

# Drug_Target_2_SwissProt_Name:
PICP_PSESR

# Drug_Target_2_Synonyms:
EC 3.4.21.100
Pepstatin-insensitive carboxyl proteinase
Pseudomonalisin precursor
Pseudomonapepsin

# Drug_Target_2_Theoretical_pI:
5.92

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cytoplasm

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
YARS

# Drug_Target_3_GenBank_ID_Gene:
U40714

# Drug_Target_3_GenBank_ID_Protein:
1184699

# Drug_Target_3_GeneCard_ID:
YARS

# Drug_Target_3_Gene_Name:
YARS

# Drug_Target_3_Gene_Sequence:
>1587 bp
ATGGGGGACGCTCCCAGCCCTGAAGAGAAACTGCACCTTATCACCCGGAACCTGCAGGAG
GTTCTGGGGGAAGAGAAGCTGAAGGAGATACTGAAGGAGCGGGAACTTAAAATTTACTGG
GGAACGGCAACCACGGGCAAACCACATGTGGCTTACTTTGTGCCCATGTCAAAGATTGCA
GACTTCTTAAAGGCAGGGTGTGAGGTAACAATTCTGTTTGCGGACCTCCACGCATACCTG
GATAACATGAAAGCCCCATGGGAACTTCTAGAACTCCGAGTCAGTTACTATGAGAATGTG
ATCAAAGCAATGCTGGAGAGCATTGGTGTGCCCTTGGAGAAGCTCAAGTTCATCAAAGGC
ACTGATTACCAGCTCAGCAAAGAGTACACACTAGATGTGTACAGACTCTCCTCCGTGGTC
ACACAGCACGATTCCAAGAAGGCTGGAGCTGAGGTGGTAAAGCAGGTGGAGCACCCTTTG
CTGAGTGGCCTCTTATACCCCGGACTGCAGGCTTTGGATGAAGAGTATTTAAAAGTAGAT
GCCCAATTTGGAGGCATTGATCAGAGAAAGATTTTCACCTTTGCAGAGAAGTACCTCCCT
GCACTTGGCTATTCAAAACGGGTCCATCTGATGAATCCTATGGTTCCAGGATTAACAGGC
AGCAAAATGAGCTCTTCAGAAGAGGAGTCCAAGATTGATCTCCTTGATCGGAAGGAGGAT
GTGAAGAAAAAACTGAAGAAGGCCTTCTGTGAGCCAGGAAATGTGGAGAACAATGGGGTT
CTGTCCTTCATCAAGCATGTCCTTTTTCCCCTTAAGTCCGAGTTTGTGATCCTACGAGAT
GAGAAATGGGGTGGAAACAAAACCTACACAGCTTACGTGGACCTGGAAAAGGACTTTGCT
GCTGAGGTTGTACATCCTGGAGACCTGAAGAATTCTGTTGAAGTCGCACTGAACAAGTTG
CTGGATCCAATCCGGGAAAAGTTTAATACCCCTGCCCTGAAAAAACTGGCCAGCGCTGCC
TACCCAGATCCCTCAAAGCAGAAGCCAATGGCCAAAGGCCCTGCCAAGAATTCAGAACCA
GAGGAGGTCATCCCATCCCGGCTGGATATCCGTGTGGGGAAAATCATCACTGTGGAGAAG
CACCCAGATGCAGACAGCCTGTATGTAGAGAAGATTGACGTGGGGGAAGCTGAACCACGG
ACTGTGGTGAGCGGCCTGGTACAGTTCGTGCCCAAGGAGGAACTGCAGGACAGGCTGGTA
GTGGTGCTGTGCAACCTGAAACCCCAGAAGATGAGAGGAGTCGAGTCCCAAGGCATGCTT
CTGTGTGCTTCTATAGAAGGGATAAACCGCCAGGTTGAACCTCTGGACCCTCCGGCAGGC
TCTGCTCCTGGTGAGCACGTGTTTGTGAAGGGCTATGAAAAGGGCCAACCAGATGAGGAG
CTCAAGCCCAAGAAGAAAGTCTTCGAGAAGTTGCAGGCTGACTTCAAAATTTCTGAGGAG
TGCATCGCACAGTGGAAGCAAACCAACTTCATGACCAAGCTGGGCTCCATTTCCTGTAAA
TCGCTGAAAGGGGGGAACATTAGCTAG

# Drug_Target_3_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_3_General_References:
12665801	Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31.
8552597	Ribas de Pouplana L, Frugier M, Quinn CL, Schimmel P: Evidence that two present-day components needed for the genetic code appeared after nucleated cells separated from eubacteria. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):166-70.
9162081	Kleeman TA, Wei D, Simpson KL, First EA: Human tyrosyl-tRNA synthetase shares amino acid sequence homology with a putative cytokine. J Biol Chem. 1997 May 30;272(22):14420-5.

# Drug_Target_3_HGNC_ID:
HGNC:12840

# Drug_Target_3_HPRD_ID:
09153

# Drug_Target_3_ID:
256

# Drug_Target_3_Locus:
1p35.1

# Drug_Target_3_Molecular_Weight:
59013

# Drug_Target_3_Name:
Tyrosyl-tRNA synthetase, cytoplasmic

# Drug_Target_3_Number_of_Residues:
527

# Drug_Target_3_PDB_ID:
1Q11

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00579	tRNA-synt_1b
PF01588	tRNA_bind

# Drug_Target_3_Protein_Sequence:
>Tyrosyl-tRNA synthetase, cytoplasmic
GDAPSPEEKLHLITRNLQEVLGEEKLKEILKERELKIYWGTATTGKPHVAYFVPMSKIAD
FLKAGCEVTILFADLHAYLDNMKAPWELLELRVSYYENVIKAMLESIGVPLEKLKFIKGT
DYQLSKEYTLDVYRLSSVVTQHDSKKAGAEVVKQVEHPLLSGLLYPGLQALDEEYLKVDA
QFGGIDQRKIFTFAEKYLPALGYSKRVHLMNPMVPGLTGSKMSSSEEESKIDLLDRKEDV
KKKLKKAFCEPGNVENNGVLSFIKHVLFPLKSEFVILRDEKWGGNKTYTAYVDLEKDFAA
EVVHPGDLKNSVEVALNKLLDPIREKFNTPALKKLASAAYPDPSKQKPMAKGPAKNSEPE
EVIPSRLDIRVGKIITVEKHPDADSLYVEKIDVGEAEPRTVVSGLVQFVPKEELQDRLVV
VLCNLKPQKMRGVESQGMLLCASIEGINRQVEPLDPPAGSAPGEHVFVKGYEKGQPDEEL
KPKKKVFEKLQADFKISEECIAQWKQTNFMTKLGSISCKSLKGGNIS

# Drug_Target_3_Reaction:
ATP + L-tyrosine + tRNATyr = AMP + diphosphate + L-tyrosyl-tRNATyr

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Not Available

# Drug_Target_3_SwissProt_ID:
P54577

# Drug_Target_3_SwissProt_Name:
SYYC_HUMAN

# Drug_Target_3_Synonyms:
EC 6.1.1.1
TyrRS
Tyrosyl--tRNA ligase

# Drug_Target_3_Theoretical_pI:
7.05

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_4_Essentiality:
Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
AY653733

# Drug_Target_4_GenBank_ID_Protein:
55416626

# Drug_Target_4_GeneCard_ID:
YARS

# Drug_Target_4_Gene_Name:
YARS

# Drug_Target_4_Gene_Sequence:
>2388 bp
ATGACTTATGTCAAAAAATATCATCCTACCACTAAATATTATGGTATTATTCATGGTGAA
AAGTATGAATTACAAGACGTTTTATTTTACAGTTTTAATTACTCTAATAGAGAAGAAGTA
TGTCCAATTAGTGGTACTGCACATAAATCCAACGGATTTTATGTAATTGAAACCAGTAAA
GGATACTTTATGAAATGCCATTCTGATAAATGTAAGAATAAAAAAGCCAAATATCTAGGT
CCAGCTGATGCGACAGATATGTTTGTTAAATGTGCCAATCAAATTGATCAACAATACCTG
ATTATGAAAGGAGGAATTGCCGATGCTCCTAAAGAACCAGTTAAAGATATCATTATCAAT
TGGTTATCCAATGATAAAATTAAAACGTTGGCTGTTCGATCTCCAATGGGAACTGGAAAG
ACAACCATGATCAAAAAAATTCTTGATCATTATGACAATATCAAAAAAATATTATGGATA
TCTCATAGACAAACTTTATCCAAACAAATTTACGGATCTTTCAAAAATCACGGATTTGTT
AATTACATGGATCAAAAAGGTAATCTGTTCGAACATGATAGACTTATTATTCAGATTGAT
AGTTTAAAAAGGATTTTTAAATACGACAAAGATTATAATACTGTATTTAAACAGTATGAT
TTGGTTATTATTGATGAGATCGAAGGGAACATGAATCATTTTATGAGTCCATATTTGAGA
AAAGATTCTGATTTTTCTGTCAGACAAACTTTTCAGAAAATGTTGAATTGTATTGATACT
GCTAAGAAACTACTAGTATTAGATGCCGATTTAGGAATGAGAAGTAAATTGTTTATTGAT
AATTTCGGTAAATCTATTGTCGTCAATAATAATTATAAACCTATCCAGAAGATTTTTGAG
ATTACTAATGATCTCTCTAGTTTTCAAGAAATTCTTCTAGCCGATATTAAAGATGGTAAA
AATGTTTGTGTTGTTTCTATGTCAGCATCTTACTTGGATAAACTTGAACCTAAATTTGCC
GGATTAAAGTATGTTATCCATACAAGTAAATCTGATGACAAACTCAAGAACGAACTTGAG
AATGTAAATTATTTCTGGAAGAAATTTCAGATATGTTGTTTTAGTCCGACAATTGAATGT
GGTGTTGATTTCAATGAGAAGCATTTTGATAAGATTTATTGTTATCTAAAAAATGGTTCC
AAAACATGTTCACAAAGAAGTTTGTTGCAAATGGTTGGTAGGATTAGACAATTAGGTAAT
AATAAAATTCTCTGTTACTATTCAGGTCCTACTAATATTGATGCTGATATTTACACTTAT
GATGATATTCTTGGATATTTTAGACATTATGAAAAAATAAATGGTCGAAAAGTATTAGAA
AATGTCGAATACAAAAAATTTATAGCCAATGGTGAAGTTACACTGAAAAGAGTTAGTGCT
AATATTTCTCTATTTGATCATATTCACATTTATAATGAAGTCGAAGAATCCAATAAAAAT
CACTCGATGTTCATAACGGTGTTGTTTAAATTAATCCAAAGAGCCGGTCATTCAATGATT
TTTAATACTGTTGAAGAACCTGAAGAAGTTGAACCTGATAATAATGTCATAAGTCATGCA
GAAATTTTATCTATGATTAATGAAACAAAATACAAAATTTCAGATCTTATGAAAAAACAA
TCTAAAAATCAATTGTCACGTACCGAAAAATTGGTCCTAGAAAAATACTTTTTTATGAAA
AATTTTGGTGTCAAAGATTCTTCTAATAAAGATGAATTCGTTAAATTTCACAAAAAATAT
GCCAATAAAGAAATCACATTCAAACATTTTAAGAGATTTTTTGGTTATGATAATCCTAAT
AATTCGATAGACGAATTAAAACATCTAGATATATTTGTTTCTAATAAGAAACCACCAAAC
AATAATAATAATAATTTCTTGGACGAACACAATGATAGTAAGGATGCTGTCAGAGATAAA
ATTATCGTTAATTTCCTTAATCTAATTCTAGATGTGAAAAAGAACGGATATGGACCAGAT
GATTTAGGCTACACATTAACTCAAGATGAACATAATACTGCTGTTTTAACTGTTGCTGAA
CAGTCTATGTACTTTGCAAACGAAGATAAATACAGACCTTTATTCAATAAAAATAAAGGT
AAATTCAAAGAAATAAATGAATACAATTTCAAACATTACTTCAAAACTGTAAAGGCTATT
CTTCAATCTTATGGAATAGATTACTATAGAGGTAATAGAAAAAGAGTCAATAGTAGAAGA
GAATTTGAATATTCTTTATCTGTCGATAAACAGATAAGGGATATTGTCGATTTTAAGTTC
GGATTATCTGATACTGTTGATGAATTTCCTAATTTGTTCCATAAATAG

# Drug_Target_4_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_4_General_References:
15486256	Raoult D, Audic S, Robert C, Abergel C, Renesto P, Ogata H, La Scola B, Suzan M, Claverie JM: The 1.2-megabase genome sequence of Mimivirus. Science. 2004 Nov 19;306(5700):1344-50. Epub 2004 Oct 14.
16510997	Abergel C, Chenivesse S, Byrne D, Suhre K, Arondel V, Claverie JM: Mimivirus TyrRS: preliminary structural and functional characterization of the first amino-acyl tRNA synthetase found in a virus. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 Feb 1;61(Pt 2):212-5. Epub 2005 Jan 20.
17855524	Abergel C, Rudinger-Thirion J, Giege R, Claverie JM: Virus-encoded aminoacyl-tRNA synthetases: structural and functional characterization of mimivirus TyrRS and MetRS. J Virol. 2007 Nov;81(22):12406-17. Epub 2007 Sep 12.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
6878

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
39722.2

# Drug_Target_4_Name:
Tyrosyl-tRNA synthetase

# Drug_Target_4_Number_of_Residues:
346

# Drug_Target_4_PDB_ID:
Not Available

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00579	tRNA-synt_1b

# Drug_Target_4_Protein_Sequence:
>Tyrosyl-tRNA synthetase
MENTDHTNNEHRLTQLLSIAEECETLDRLKQLVDSGRIFTAYNGFEPSGRIHIAQALITV
MNTNNIIECGGQMIIYIADWFAKMNLKMNGDINKIRELGRYFIEVFKACGINLDGTRFIW
ASEFIASNPSYIERMLDIAEFSTISRVKRCCQIMGRNESDCLKASQIFYPCMQAADVFEL
VPEGIDICQLGIDQRKVNMLAIEYANDRGLKIPISLSHHMLMSLSGPKKKMSKSDPQGAI
FMDDTEQEVSEKISRAYCTDETFDNPIFEYIKYLLLRWFGTLNLCGKIYTDIESIQEDFS
SMNKRELKTDVANYINTIIDLVREHFKKPELSELLSNVKSYQQPSK

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Catalyzes the attachment of tyrosine to tRNA(Tyr) in a two-step reaction:tyrosine is first activated by ATP to form Tyr- AMP and then transferred to the acceptor end of tRNA(Tyr) (By similarity)

# Drug_Target_4_SwissProt_ID:
Q5UPJ7

# Drug_Target_4_SwissProt_Name:
SYY_MIMIV

# Drug_Target_4_Synonyms:
TyrRS
Tyrosine--tRNA ligase

# Drug_Target_4_Theoretical_pI:
5.16

# Drug_Target_4_Transmembrane_Regions:
None

#END_DRUGCARD DB03978
